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Melanoma
Christina Pfeifer BSN, RN, ATC
Introduction
Topic
• The	chosen	topic	for	the	poster	project	was	malignant	melanoma.		
• The	incidence	of	malignant	melanoma	has	continued	to	increase	over	the	years	and	it	has	become	one	of	the	top	five	most	common	cancers	in	the	United	States	(Kauffmann	&	Chen,	2014).	
• The incidence	of	melanoma	has	also	increased	worldwide	( Azoury	&	Lange,	2014).
• 5th and 7th most common cancerin men and women respectively	(Azoury	&	Lange	2014).
Signs & Symptoms ReferencesAmerican	Cancer	Society.	(2018) Signs	and	Symptoms	of	Melanoma	Skin	Cancer.	Retrieved	July	17,	2018	from	https://www.cancer.org/cancer/melanoma-skin-cancer/detection-diagnosis-staging/signs-and-symptoms.htmlAzoury,	S.C.,	Lange,	J.	R.	(2014).	Epidemiology,	risk	factors,	prevention,	and	early	detection	of	melanoma.	Surgical	Clinics	of	North	America	94(5),	945-962.	https://doi.org/10.1016/j.suc.2014.07.013Hawryluk,	E.	B.,	&	Tsao,	H.	(2014).	Melanoma:	clinical	features	and	genomic	insights.	Cold	Spring	Harbor	Perspectives	in	Medicine,	4(9),	a015388.	http://doi.org/10.1101/cshperspect.a015388Kauffmann,	R.M.,	Chen,	S.L.	(2014).	Workup	and	staging	of	malignant	melanoma.	Surgical	Clinics	of	North	America	94(5),	963-972.	https://doi.org/10.1016/j.suc.2014.07.001McCance,	K.	L.	&	Huether,	S.	E.	(2019).	Pathophysiology:	The	biologic	basis	for	disease	in	adults	and	children	(8th	ed.).	St.	Louis,	Mo.:	Elsevier,	Inc.	Mrazek,	A.	A.,	&	Chao,	C.	(2014).	Surviving	cutaneous	melanoma:	a	clinical	review	of	follow-up	practices,	surveillance,	and	management	of	recurrence.	The	Surgical	Clinics	of	North	America,	94(5),	989–1002.	http://doi.org/10.1016/j.suc.2014.07.003Soura,	E.,	Eliades,	P.,	Shannon,	K.,	Stratigos,	A.,	&	Tsao,	H.	(2016).	Hereditary	melanoma:	update	on	syndromes	and	management	- genetics	of	familial	atypical	multiple	mole	melanoma	syndrome.	Journal	of	the	American	Academy	of	Dermatology,	74(3),	395–407.	http://doi.org/10.1016/j.jaad.2015.08.038
• A	new	abnormal	looking	growth	or	an	existing	mole	that	undergoes	changes	should	be	evaluated
Ø Early	signs	of	melanoma	are	described	by	the	mnemonic	“ABCDE”	(Kauffman	&	Chen,	2014,	p.	964	&	American	Cancer	Society,	2018)
o A	=	asymmetry	and	refers	to	one	half	of	the	mole	or	growth	not	matching	the	other	half.
o B	=	border	and	refers	to	irregular	edges.
o C	=	color	and	refers	to	the	color	being	inconsistent	and	may	include	different	shades	or	patches
o D	=	Diameter	and	refers	to	the	mole	being	greater	than	6mm	across	(although	melanomas	can	be	smaller	than	6mm)
o E	=	Evolution	or	Elevation	referring	to	the	mole	changing	in	size,	shape	or	color	or	becoming	elevated.
• According	to	the	American	Cancer	Society	other	signs	of	potential	melanoma	are
Ø “A	sore	that	does	not	heal”
Ø “Spread	of	pigment	from	the	boarder	of	a	spot	into	surrounding	skin”
Ø “Redness	or	new	swelling	beyond	the	border	of	the	mole”
Ø “Change	in	sensation,	such	as	itchiness,	tenderness	or	pain”
Ø “Change	in	the	surface	of	a	mole	- scaliness,	oozing,	bleeding,	or	the	appearance	of	a	lump	or	bump”
Explanation for Topic Choice
• The	appeal	in	the	topic	derived	from	diagnosis	of	multiple	family	members,	leading	to	an	interest	in	enhancing	personalknowledge.
• Goal	to	further	educate	others	about	malignant	melanoma,	its	origin,	risk	factors, preventionand treatment.
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With	the	incidence	of	melanoma	continuing	to	increase	it	is	important	to	obtain	a	complete	history	and	physical.		Family	and	self	history	is	of	great	importance.	Any	suspicious	lesions	should	be	biopsied	and	staged		in	order	to	allow	the	patient	to	have	the	best	optimal	outcomes.
Conclusion
“A molecular map of melanoma. Heritable loci with risk alleles or single-nucleotide 
polymorphisms are shown in italics with asterisks (e.g., CDKN2A*). Red and gray colors indicate 
somatic alterations that result in gain of function (i.e., oncogenes such as BRAF) or loss of 
function (i.e., tumor-suppressor genes such as PTEN), respectively. (Figure based on modified 
data from Tsao et al. 2012)” (Hawryluk & Tsao, 2014, p. 4)
Pathophysiology Implications for 
Nursing CareFigure 1. Mnemonic “ABCDE”
Figure 2.
Risk factors for melanoma 
(Azoury & Lange, 2014, p.949)
• Acquired	&	Environmental
Ø Ultraviolet	light
Ø Cancer	history	
o Significantly	increases	risk	regardless	of	the	type	of	skin	cancer
Ø Immunosuppression
Ø Socioeconomic	Status
Ø Obesity
Ø Occupation/Exposure
• Demographics	and	Phenotypes
Ø Race	- Caucasian
Ø Male	
Ø Age	>	65
Ø Light	hair,	light	eyes,	fair	skin
Ø Multiple	atypical	Nevi
• Familial,	Genetics	&	Epigenetics
Ø microRNA
Ø High,	low	risk	Allele
Ø MITF,	other	mutations
Underlying
• Melanin	is	cells	of	the	skin	from	which	pigment	is	generated	and	it	is	synthesized	by	melanocytes	(McCance	&	Huether,	2019,	p.85.
• Melanoma	is	an	aggressive	malignancy	borne	of	melanocytes	(Hawryluk	&	Tsao,	2014,	p.2).
• The pathophysiology	sequence	leading	to	melanoma	is	not	well	defined	and	the	molecular	trigger	for	transformation tomelanoma is unknown.	However,	certain	genes	and	signaling	pathways	have	been	discovered	to	have	a	role	in	the	pathophysiology	of	melanoma	(Hawryluk	and	Tsao,	2014,	p.2).
Significance
• Melanoma	is	a	“molecularly	heterogeneous disease”	and researchhas	identified	many	genetic	alterations.	Identifying	genetic	mutations	can	provide	a	positive	clinical	impact onpatient care	(Hawryluk	and	Tsao,	2014,	p.1).
• Germline	melanoma
ØCDKN2A	(Hawryluk	&	Tsao,	2014)
o Cyclin-dependent		kinase	inhibitor	2A	encode	tumor	suppressor	proteins	which	function	in	cell	cycle	arrest.
o High	penetrance	gene
o 70%	increased	risk	of	melanoma	for	those	who	carry	the	mutation
o Most	common	mutation	in	hereditary	melanoma.	“Familial	melanoma	in	the	presence	of	multiple	atypical	nevi	should	raise	suspicion	for	a	germline	CDKN2A	mutation	(Soura	et	al.	2015,	p.	395)
ØBRAF	(Hawryluk	&	Tsao,	2014)
o Associated	with	intense	intermittent	UV	radiation	exposure
o Most	often	found	in	the	younger	population
o More	than	60%	of	cutaneous	melanoma	have	BRAF	mutation
o In	initial	studies	tumor	regression	was	achieved	with	selective	inhibition	of	BRAF.
(Kauffmann & Chen, 2014, p. 964)
• The	nurse	practitioner	(NP)	has	the	ability	to	help	patients	prevent,	detect,	and	treat	malignant	melanoma.
• Educating	patients	on	prevention	strategies	can	help	decrease	their	risk	of	melanoma,	such	as
Ø Wearing	sunscreen	and	protective	clothing,	limiting	exposure	time	in	the	sun,	avoiding	tanning	beds,	and	checking	and	monitoring	moles	and	growths	on	the	skin.
• Following	the	mnemonic	“ABCDE”	can	help	the	patient	as	well	as	the	provider	spot	a	potential	melanoma.
• Should	a	suspicious	lesion	be	noted	it	should	be	biopsied	and	if	found	to	be	melanoma,	staged	appropriately	according	to	the	depth	of	the	tumor	(Breslow	thickness	test)	and	the	mitotic	rate	(Mrazek	&	Chao,	2014)
• It is also important to obtain afamily history	of	melanoma	to	determine	a	possible	genetic	link.
